AZD-1402
- Generic Name
- AZD-1402
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Elarekibep in Healthy Japanese Subjects
Phase 1
Terminated
- Conditions
- Healthy Subjects (Indication: Asthma)
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-04-03
- Last Posted Date
- 2023-07-18
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 30
- Registration Number
- NCT05794672
- Locations
- 🇬🇧
Research Site, Harrow, United Kingdom
Efficacy and Safety of Inhaled AZD1402 Administered for Four Weeks in Adults With Asthma on Medium-to-High Dose Inhaled Corticosteroids
Phase 2
Terminated
- Conditions
- Asthma
- Interventions
- Drug: PlaceboDrug: Short acting beta agonist (SABA) (rescue medication)Drug: Run-in medications (ICS-LABA combination)
- First Posted Date
- 2020-11-24
- Last Posted Date
- 2023-08-16
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 72
- Registration Number
- NCT04643158
- Locations
- 🇬🇧
Research Site, London, United Kingdom
Study to Assess Effect of Device and Formulation on Pharmacokinetics (PK) of AZD1402
- First Posted Date
- 2019-04-19
- Last Posted Date
- 2019-06-21
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 18
- Registration Number
- NCT03921268
- Locations
- 🇬🇧
Research Site, Harrow, United Kingdom
Study of Multiple Doses of PRS-060 Administered by Oral Inhalation in Subjects With Mild Asthma
- First Posted Date
- 2018-07-02
- Last Posted Date
- 2020-12-24
- Lead Sponsor
- Pieris Australia Pty Ltd
- Target Recruit Count
- 76
- Registration Number
- NCT03574805
- Locations
- 🇦🇺
Linear, Nedlands, West Australia, Australia
🇦🇺CMAX, Adelaide, South Australia, Australia
🇦🇺Q-Pharm, Herston, Queensland, Australia
Study of a Single Dose of PRS-060 Administered by Oral Inhalation or IV Infusion in Healthy Subjects
- First Posted Date
- 2017-12-27
- Last Posted Date
- 2020-11-16
- Lead Sponsor
- Pieris Australia Pty Ltd
- Target Recruit Count
- 72
- Registration Number
- NCT03384290
- Locations
- 🇦🇺
Nucleus Network Limited, Melbourne, Victoria, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath